According to Anavex Life Sciences latest financial reports the total liabilities of AVXL is $12.53M, an increase of 22.71% to 2022. At the end of 2022 company had $10.21M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Anavex Life Sciences is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $12.53M | 22.71% |
2022 | $10.21M | -5.41% |
2021 | $10.80M | 47.81% |
2020 | $7.31M | 44.96% |
2019 | $5.04M | - |